ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of ...

From insulin to immunotherapies, clinical trials have powered some of the most important medical breakthroughs of our time.

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

Clinical trials often face low accrual and retention, and involving communities in their planning and conduct is crucial to ...

DelveInsight's " Autosomal Dominant Optic Atrophy Market Insight, Epidemiology And Market Forecast - 2034 " report delivers comprehensive insights into the autosomal dominant optic atrophy treatment ...

Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how a focused GLP-1 task force and deep market insights are helping sponsors stand out in ...

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of all regional markets by country and split of each ...

A patient shares how an event about clinical trials at Moores Cancer Center brought a community together to educate and ...

North America clinical trials market is projected to grow by 7.1% annually in the forecast period and reach $39,268.7 million by 2031, driven by the increasing number of clinical trials and increase ...

Collection of ethnicity data in clinical research has been poor historically, but is essential to ensure that interventions are effective and safe across diverse populations. These data are needed to ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 clini ...